Openbookopenbook
Equity
Decibel Cannabis Company Inc(DBCCF)
USD --+0.00%
Reward69High
Risk55Medium-High
📊75%Data
Revenue growing 37% YoY
DBCCF
+0.0 · +0.00%
USD · OTCQB
Decibel Cannabis Company Inc | Healthcare
Growth Machine
Market Cap:42.98M
ℹ️
Reward Rating
69
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
55
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on DBCCF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Decibel Cannabis Company Inc?

, an integrated cannabis company, engages in the cannabis cultivation in Canada.

DBCCF · Verdict

Solid reward · elevated risk

DBCCF stands out on growth and valuation, but watch the profitability signal.

Based on 88% data coverage

DBCCF · Verdict

What’s working & what to watch

Strengths 2

  • Growth90/100

    Rev +20.8% CAGR · earnings +75.8%

  • Valuation85/100

    P/E 7.6×

Watchouts 2

  • Profitability39/100

    10% net margin · 22% ROE

  • Balance sheet42/100

    Current ratio 1.32

Model-based scoring. For information only — not financial advice.

What is Decibel Cannabis Company Inc?

, an integrated cannabis company, engages in the cannabis cultivation in Canada. It is involved in the extraction, processing, and manufacturing of vape cartridges and glass tube packaging for pre-rolls. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 42.98M, and a P/E ratio of 3.7x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: High (69)

The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap42.98M
P/E Ratio3.725
Dividend YieldN/A
52 Week High0.109
52 Week Low0.0336
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding577M
No. of EmployeesN/A
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTCQB
Beta0.937
CurrencyUSD · Reports in CAD
Websitewww.decibelcc.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.